Plus Therapeutics outlines REYOBIQ expansion plans and CNSide launch timeline

featured-image

Earnings Call Insights: Plus Therapeutics (PSTV) Q4 2024 Management View CEO Marc Hedrick announced the completion of equity financing that raised $15 million in gross proceeds, with additional funding from accelerated grant proceeds totaling $2 million. These funds provide financial support through key milestones.